Posted on 11/9/20
Editas Medicine Appoints Lisa A. Michaels, M.D., as Chief Medical Officer
CAMBRIDGE, Mass., Nov. 09, 2020 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (Nasdaq: EDIT), a leading genome editing company, today announced that it named Lisa A. Michaels, . . .
Posted on 11/9/20
Inozyme Pharma Appoints Kevin B. Johnson, Ph.D., MBA, as Senior Vice President
BOSTON, Nov. 09, 2020 (GLOBE NEWSWIRE) -- Inozyme Pharma, Inc. (Nasdaq: INZY), a rare disease biopharmaceutical company developing novel therapeutics for the treatment of diseases of . . .
Posted on 11/9/20
Great Elm Capital Corp. Announces Third Quarter 2020 Financial Results
WALTHAM, Mass., Nov. 09, 2020 (GLOBE NEWSWIRE) -- Great Elm Capital Corp.(NASDAQ: GECC), a business development company (BDC), today announced its financial results for the third . . .
Posted on 11/9/20
Morphic Announces Corporate Highlights and Third Quarter 2020 Financial Results
WALTHAM, Mass., Nov. 09, 2020 (GLOBE NEWSWIRE) -- Morphic Therapeutic (Nasdaq: MORF), a biopharmaceutical company developing a new generation of oral integrin therapies for the treatment . . .
Posted on 11/9/20
Baudax Bio Reports Third Quarter 2020 Financial Results
MALVERN, Pa., Nov. 09, 2020 (GLOBE NEWSWIRE) -- Baudax Bio, Inc. (NASDAQ:BXRX), a pharmaceutical company focused on therapeutics for acute care settings, today reported financial results . . .
Posted on 11/9/20
Wave Life Sciences Reports Third Quarter 2020 Financial Results and Provides Business Update
CAMBRIDGE, Mass., Nov. 09, 2020 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage genetic medicines company committed to delivering life-changing treatments for people . . .
Posted on 11/9/20
Duck Creek Technologies Proposes Secondary Offering of Common Stock
Boston, MA, Nov. 09, 2020 (GLOBE NEWSWIRE) -- Duck Creek Technologies, Inc. (Nasdaq: DCT), a provider of SaaS-delivered enterprise software to the property & casualty insurance . . .
Posted on 11/9/20
Allena Pharmaceuticals Announces Third Quarter 2020 Financial Results and Provides Business Update
NEWTON, Mass., Nov. 09, 2020 (GLOBE NEWSWIRE) -- Allena Pharmaceuticals (NASDAQ:ALNA), a late-stage, biopharmaceutical company dedicated to developing and commercializing first-in-class, oral enzyme therapeutics to treat . . .
Posted on 11/9/20
Homology Medicines Announces $60 Million Equity Investment from Pfizer
BEDFORD, Mass., Nov. 09, 2020 (GLOBE NEWSWIRE) -- Homology Medicines, Inc. (Nasdaq: FIXX), a genetic medicines company, announced today that Pfizer Inc. (NYSE: PFE) has agreed . . .
Posted on 11/9/20
Rubius Therapeutics Reports Third Quarter 2020 Financial Results
CAMBRIDGE, Mass., Nov. 09, 2020 (GLOBE NEWSWIRE) -- Rubius Therapeutics, Inc. (Nasdaq:RUBY), a clinical-stage biopharmaceutical company that is genetically engineering red blood cells to create an . . .
Posted on 11/9/20
2020’s Best Cities for Veterans & Military Money Survey – WalletHub
With Veterans Day approaching and the COVID-19 pandemic leading to an increase in veteran unemployment, the personal-finance website WalletHub today released its report on 2020’s Best . . .
Posted on 11/9/20
Provident Healthcare Partners Advises Palmetto Retina Center In Its Partnership With Retina Consultants Of America
Palmetto Retina Center, comprised of five retina specialists across six offices serving South Carolina, has partnered with Retina Consultants of America (RCA), a portfolio company of . . .
Posted on 11/9/20
Cogent Biosciences Reports Third Quarter 2020 Financial Results and Provides Corporate Updates
Cogent Biosciences, Inc. (Nasdaq: COGT), a biotechnology company focused on developing precision therapies for genetically defined diseases, today announced financial results for the third quarter ended . . .
Posted on 11/9/20
Service Properties Trust Announces Third Quarter 2020 Results
NEWTON, Mass.--(BUSINESS WIRE)--Service Properties Trust (Nasdaq: SVC) today announced its financial results for the quarter and nine months ended September 30, 2020:John Murray, President and Chief . . .
Posted on 11/9/20
Seres Therapeutics Reports Third Quarter 2020 Financial Results and Provides Business Updates
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Seres Therapeutics, Inc., (Nasdaq: MCRB) today reported financial results from the third quarter ended September 30, 2020, and provided business updates.“Supported by our positive, . . .
Posted on 11/9/20
Decibel Therapeutics Raises $82M Series D
Decibel Therapeutics, a clinical-stage biotechnology company developing novel restorative gene therapeutics to treat hearing loss and balance disorders, today announced the closing of an oversubscribed Series . . .
Posted on 11/9/20
Ribon Therapeutics Appoints Emma Reeve to Board
Ribon Therapeutics, a clinical-stage oncology company developing first-in-class therapeutics targeting stress response pathways, today announced the appointment of Emma Reeve to its Board of Directors.
Posted on 11/9/20
Mersana Therapeutics Announces Third Quarter 2020 Financial Results and Provides Business Update
CAMBRIDGE, Mass., Nov. 09, 2020 (GLOBE NEWSWIRE) -- Mersana Therapeutics, Inc. (NASDAQ:MRSN), a clinical-stage biopharmaceutical company focused on discovering and developing a pipeline of antibody-drug conjugates . . .
Posted on 11/9/20
LogicBio Therapeutics Reports Third Quarter 2020 Financial Results and Provides Business Update
LEXINGTON, Mass., Nov. 09, 2020 (GLOBE NEWSWIRE) -- LogicBio Therapeutics, Inc. (Nasdaq:LOGC), a company dedicated to extending the reach of genetic medicine with pioneering targeted delivery . . .
Posted on 11/9/20
10 States Disbursing Huge Social Security Checks
It's no secret: Social Security is a foundational program for our nation's retired workers. Each month, the program pays out benefits to nearly 65 million people, . . .
Posted on 11/9/20
Charles River Labs: And The Beat Goes On
SummaryCharles River reported Q3 2020 results that beat the top- and bottom-line estimates. Moreover, the company has beat analysts' earnings estimates in each of the last . . .
Posted on 11/9/20
Berkshire Hathaway Seems To Have Learned Something From Its Largest Holding
SummaryBerkshire Hathaway has an impressive portfolio of assets generating strong operating cash flow and impressive investments.The company has 2% quarterly buybacks moving towards 8% annualized. The . . .
Posted on 11/9/20
Moderna and Pfizer: A Tale of Two mRNA Coronavirus Vaccine Stocks
Ten programs are currently involved in phase 3 trials. But Moderna and Pfizer are arguably the closest to earning Emergency Use Authorizations (EUAs) for their vaccine . . .
Posted on 11/9/20
Here's Why Vertex Pharmaceuticals Fell 23.4% in October
What happenedShares of Vertex Pharmaceuticals (NASDAQ:VRTX) fell 23.4% in October, according to data from S&P Global Market Intelligence after the biotech discontinued development of a drug . . .
Posted on 11/9/20
This Buffett-Owned REIT Is Still Floundering in the Pandemic
When it was spun off from Sears Holdings a little more than five years ago, Seritage Growth Properties (NYSE:SRG) had a promising strategy. It paid $2.7 . . .

